Ortin Global Q1 Results
- BSE: 539287
- NSE: ORTINGLOBE
- ISIN: INE749B01020
- Sector: Biotechnology & Drugs
BSE
13.70
0.51 (3.87%)
0.51 (3.87%)Volume4.21 K
Updated: Tue 10 Feb, 2026 | 15:25:35
NSE
13.640.64 (4.92%)
0.64 (4.92%)Volume8.27 K
Updated: Tue 10 Feb, 2026 | 15:29:07
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Ortin Global Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.24 | 0.25 | -1.58% | 0.31 | -22.09% |
| Depreciation/ Amortization | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% |
| Operating Income | -0.20 | -0.20 | 0.79% | -0.10 | 96.15% |
| Net Income | -0.18 | -0.16 | 6.89% | -0.10 | 70.29% |
| Other Operating Expenses Total | 0.16 | 0.20 | -20.74% | 0.16 | 0.50% |
| Net Income Before Taxes | -0.16 | -0.16 | 1.05% | -0.10 | 60.81% |
| Total Revenue | 0.04 | 0.05 | -12.14% | 0.21 | -80.92% |
| Selling/ General/ Admin Expenses Total | 0.04 | 0.03 | 1.72% | 0.04 | -13.20% |
| Diluted Normalized EPS | -0.22 | -0.20 | 9.37% | -0.13 | 69.23% |